Cargando…

The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH

The lncRNA HOTAIR is a critical regulator of cancer progression. Chromatin remodeling factor LSH is critical for normal development of plants and mammals. However, the underlying mechanisms causing this in cancer are not entirely clear. The functional diversification of the FOXA1 and FOXA2 contribut...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ranran, Shi, Ying, Chen, Ling, Jiang, Yiqun, Mao, Chao, Yan, Bin, Liu, Shuang, Shan, Bin, Tao, Yongguang, Wang, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675985/
https://www.ncbi.nlm.nih.gov/pubmed/26658322
http://dx.doi.org/10.1038/srep17826
_version_ 1782405087129239552
author Wang, Ranran
Shi, Ying
Chen, Ling
Jiang, Yiqun
Mao, Chao
Yan, Bin
Liu, Shuang
Shan, Bin
Tao, Yongguang
Wang, Xiang
author_facet Wang, Ranran
Shi, Ying
Chen, Ling
Jiang, Yiqun
Mao, Chao
Yan, Bin
Liu, Shuang
Shan, Bin
Tao, Yongguang
Wang, Xiang
author_sort Wang, Ranran
collection PubMed
description The lncRNA HOTAIR is a critical regulator of cancer progression. Chromatin remodeling factor LSH is critical for normal development of plants and mammals. However, the underlying mechanisms causing this in cancer are not entirely clear. The functional diversification of the FOXA1 and FOXA2 contributes to the target genes during evolution and carcinogenesis. Little is known about the ratio of FOXA1 to FOXA2 in cancer. We here found that both HOTAIR and LSH overexpression was significantly correlated with poor survival in patients with lung adenocarcinoma cancer (ADC). Also, the ratio of FOXA1 and FOXA2 is linked with poor survival in patients with lung ADC. HOTAIR regulates the ratio of FOXA1 to FOXA2 and migration and invasion. HOTAIR and the ratio of FOXA1 to FOXA2 are negatively correlated. HOTAIR knockdown inhibits migration and invasion. HOTAIR is associated with LSH, and this association linked with the binding of LSH in the promoter of FOXA1, not FOXA2. Targeted inhibition of HOTAIR suppresses the migratory and invasive properties. These data suggest that HOTAIR is an important mediator of the ratio of FOXA1 and FOXA2 and LSH involves in, and suggest that HOTAIR inhibition may represent a promising therapeutic option for suppressing lung ADC progression.
format Online
Article
Text
id pubmed-4675985
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-46759852015-12-16 The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH Wang, Ranran Shi, Ying Chen, Ling Jiang, Yiqun Mao, Chao Yan, Bin Liu, Shuang Shan, Bin Tao, Yongguang Wang, Xiang Sci Rep Article The lncRNA HOTAIR is a critical regulator of cancer progression. Chromatin remodeling factor LSH is critical for normal development of plants and mammals. However, the underlying mechanisms causing this in cancer are not entirely clear. The functional diversification of the FOXA1 and FOXA2 contributes to the target genes during evolution and carcinogenesis. Little is known about the ratio of FOXA1 to FOXA2 in cancer. We here found that both HOTAIR and LSH overexpression was significantly correlated with poor survival in patients with lung adenocarcinoma cancer (ADC). Also, the ratio of FOXA1 and FOXA2 is linked with poor survival in patients with lung ADC. HOTAIR regulates the ratio of FOXA1 to FOXA2 and migration and invasion. HOTAIR and the ratio of FOXA1 to FOXA2 are negatively correlated. HOTAIR knockdown inhibits migration and invasion. HOTAIR is associated with LSH, and this association linked with the binding of LSH in the promoter of FOXA1, not FOXA2. Targeted inhibition of HOTAIR suppresses the migratory and invasive properties. These data suggest that HOTAIR is an important mediator of the ratio of FOXA1 and FOXA2 and LSH involves in, and suggest that HOTAIR inhibition may represent a promising therapeutic option for suppressing lung ADC progression. Nature Publishing Group 2015-12-11 /pmc/articles/PMC4675985/ /pubmed/26658322 http://dx.doi.org/10.1038/srep17826 Text en Copyright © 2015, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Wang, Ranran
Shi, Ying
Chen, Ling
Jiang, Yiqun
Mao, Chao
Yan, Bin
Liu, Shuang
Shan, Bin
Tao, Yongguang
Wang, Xiang
The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH
title The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH
title_full The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH
title_fullStr The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH
title_full_unstemmed The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH
title_short The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH
title_sort ratio of foxa1 to foxa2 in lung adenocarcinoma is regulated by lncrna hotair and chromatin remodeling factor lsh
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675985/
https://www.ncbi.nlm.nih.gov/pubmed/26658322
http://dx.doi.org/10.1038/srep17826
work_keys_str_mv AT wangranran theratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh
AT shiying theratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh
AT chenling theratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh
AT jiangyiqun theratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh
AT maochao theratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh
AT yanbin theratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh
AT liushuang theratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh
AT shanbin theratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh
AT taoyongguang theratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh
AT wangxiang theratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh
AT wangranran ratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh
AT shiying ratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh
AT chenling ratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh
AT jiangyiqun ratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh
AT maochao ratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh
AT yanbin ratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh
AT liushuang ratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh
AT shanbin ratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh
AT taoyongguang ratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh
AT wangxiang ratiooffoxa1tofoxa2inlungadenocarcinomaisregulatedbylncrnahotairandchromatinremodelingfactorlsh